SCHEMBL26293017

SCHEMBL26293017

Cc1ccc2c(c1)oc1cc(C)cc(C)c12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 3/20 0.49
▸ ESR2 Q92731 3/20 0.49
▸ MAOB P27338 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ KDM4E B2RXH2 1/20 0.41
▸ PON1 P27169 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ MAPT P10636 5/20 0.41
▸ CDC25A P30304 1/20 0.40
▸ CDC25C P30307 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ AHR P35869 1/20 0.37
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26293022 0.86 MAPT (0.42) ESR1ESR2ALDH1A1HPGDKDM4E
SCHEMBL31362933 0.85 AHR (0.56) ESR1ESR2GAAKDM4EPON1
SCHEMBL17920843 0.82 MAOA (0.44) ESR1ESR2MAOBALDH1A1HPGD
SCHEMBL11711426 0.82 CYP1A2 (0.47) ESR1ESR2MAOBALDH1A1HPGD
SCHEMBL9927267 0.80 MAOB (0.53) MAOBALDH1A1HPGDGAAKDM4E
SCHEMBL21315938 0.80 MAOB (0.39) ESR1ESR2MAOBALDH1A1HPGD
SCHEMBL12433585 0.78 MAOA (0.41) MAOBALDH1A1HPGDGAAKDM4E
SCHEMBL20156784 0.78 MAOB (0.44) MAOBALDH1A1HPGDGAAKDM4E
SCHEMBL15195120 0.76 MAOB (0.50) MAOBALDH1A1HPGDGAAKDM4E
SCHEMBL862364 0.75 MAOB (0.46) MAOBALDH1A1HPGDGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234937-A1 INDENOAZANAPHTHALENES MERCK PATENT GMBH (DE) 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234937-A1 INDENOAZANAPHTHALENES NQO1, CYP2D6, SQOR ESR1 205/4885ESR2 712/4885MAOB 456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback